Panacea Pharmaceuticals
Recent Finacing
Series E
Recent Raise
$15M
Panacea Pharmaceuticals develops nanoparticle-based therapeutic cancer vaccines to boost antibody and cellular anti-tumor responses, and develops anti-HAAH antibody radio-imaging/therapy, neuroprotectant BrainGuard, diagnostics, and adjuncts.
Highlights
Focus Areas
Biotechnology
Health Care
Pharmaceutical
Financials
$15M
Total Raised
1
Funding round